{
  "success": true,
  "pagesUsed": [
    9,
    10,
    11,
    20,
    21,
    22
  ],
  "modelUsed": "gemini-3-flash-preview",
  "eligibility": {
    "eligibilityCriterionItems": [
      {
        "id": "eci_1",
        "name": "Treatment-resistant depression definition",
        "text": "Treatment-resistant depression is defined as a lack of clinically meaningful improvement after treatment with at least 2 different antidepressant agents prescribed in adequate doses for adequate duration. The upper limit of ≤5 antidepressants is only applicable to the past 2 years of a current episode of depression in cases where the current episode is >2 years.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_2",
        "name": "Nonresponse improvement threshold",
        "text": "Nonresponse defined as ≤25% improvement per Massachusetts General Hospital - Antidepressant Treatment Response Questionnaire (MGH-ATRQ), which specifies at least 6 weeks of treatment at a minimum therapeutic dose.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_3",
        "name": "Site Independent Qualification Assessment",
        "text": "Site Independent Qualification Assessment confirms the subject's current major depressive episode, antidepressant treatment response in the current depressive episode, and severity of depression (required at Week 1 to be MADRS total score ≥28).",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_4",
        "name": "Thyroid function requirements",
        "text": "If the thyroid-stimulating hormone (TSH) value is outside the normal reference range, then the free thyroxine (FT4) level will be assessed. If the FT4 level is normal, then the subject can be enrolled. If the FT4 level is outside the normal reference range, then the subject is not eligible.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_5",
        "name": "Contraceptive requirements",
        "text": "Contraceptive use by men or women should be consistent with local regulations regarding the use of contraceptive methods for subjects participating in clinical studies. Includes strengthened definitions of women who are not of childbearing potential and requirements for highly effective methods of contraception.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_6",
        "name": "Transferred-entry subject alignment",
        "text": "Transferred-entry subjects must meet the same criteria at the point of entry to this study as the direct-entry subjects at the same time point (ie, beginning of optimization phase).",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_7",
        "name": "Severe renal impairment exclusion",
        "text": "Exclude subjects with severe renal impairment (creatinine clearance <30 mL/min).",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_8",
        "name": "Transferred-entry exclusion alignment",
        "text": "Transferred-entry subjects must meet none of the exclusion criteria applicable to direct-entry subjects at the beginning of the optimization phase.",
        "instanceType": "EligibilityCriterionItem"
      }
    ],
    "eligibilityCriteria": [
      {
        "id": "ec_1",
        "identifier": "I3",
        "category": {
          "code": "Inclusion",
          "codeSystem": "USDM",
          "decode": "Inclusion"
        },
        "criterionItemId": "eci_1",
        "instanceType": "EligibilityCriterion",
        "name": "Treatment-resistant depression definition",
        "nextId": "ec_2"
      },
      {
        "id": "ec_2",
        "identifier": "I3.1",
        "category": {
          "code": "Inclusion",
          "codeSystem": "USDM",
          "decode": "Inclusion"
        },
        "criterionItemId": "eci_2",
        "instanceType": "EligibilityCriterion",
        "name": "Nonresponse improvement threshold",
        "previousId": "ec_1",
        "nextId": "ec_3"
      },
      {
        "id": "ec_3",
        "identifier": "I5",
        "category": {
          "code": "Inclusion",
          "codeSystem": "USDM",
          "decode": "Inclusion"
        },
        "criterionItemId": "eci_3",
        "instanceType": "EligibilityCriterion",
        "name": "Site Independent Qualification Assessment",
        "previousId": "ec_2",
        "nextId": "ec_4"
      },
      {
        "id": "ec_4",
        "identifier": "I7",
        "category": {
          "code": "Inclusion",
          "codeSystem": "USDM",
          "decode": "Inclusion"
        },
        "criterionItemId": "eci_4",
        "instanceType": "EligibilityCriterion",
        "name": "Thyroid function requirements",
        "previousId": "ec_3",
        "nextId": "ec_5"
      },
      {
        "id": "ec_5",
        "identifier": "I9.1",
        "category": {
          "code": "Inclusion",
          "codeSystem": "USDM",
          "decode": "Inclusion"
        },
        "criterionItemId": "eci_5",
        "instanceType": "EligibilityCriterion",
        "name": "Contraceptive requirements",
        "previousId": "ec_4",
        "nextId": "ec_6"
      },
      {
        "id": "ec_6",
        "identifier": "I15",
        "category": {
          "code": "Inclusion",
          "codeSystem": "USDM",
          "decode": "Inclusion"
        },
        "criterionItemId": "eci_6",
        "instanceType": "EligibilityCriterion",
        "name": "Transferred-entry subject alignment",
        "previousId": "ec_5"
      },
      {
        "id": "ec_7",
        "identifier": "E31",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_7",
        "instanceType": "EligibilityCriterion",
        "name": "Severe renal impairment exclusion",
        "nextId": "ec_8"
      },
      {
        "id": "ec_8",
        "identifier": "E32",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_8",
        "instanceType": "EligibilityCriterion",
        "name": "Transferred-entry exclusion alignment",
        "previousId": "ec_7"
      }
    ],
    "summary": {
      "inclusionCount": 6,
      "exclusionCount": 2,
      "totalCount": 8
    },
    "population": {
      "id": "pop_1",
      "name": "Study Population",
      "includesHealthySubjects": false,
      "criterionIds": [
        "ec_1",
        "ec_2",
        "ec_3",
        "ec_4",
        "ec_5",
        "ec_6",
        "ec_7",
        "ec_8"
      ],
      "instanceType": "StudyDesignPopulation",
      "description": "Target population defined by eligibility criteria"
    }
  },
  "rawResponse": {
    "eligibilityCriteria": [
      {
        "id": "ec_1",
        "name": "Treatment-resistant depression definition",
        "identifier": "I3",
        "category": {
          "code": "Inclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Inclusion Criterion"
        },
        "criterionItemId": "eci_1",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_2",
        "name": "Nonresponse improvement threshold",
        "identifier": "I3.1",
        "category": {
          "code": "Inclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Inclusion Criterion"
        },
        "criterionItemId": "eci_2",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_3",
        "name": "Site Independent Qualification Assessment",
        "identifier": "I5",
        "category": {
          "code": "Inclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Inclusion Criterion"
        },
        "criterionItemId": "eci_3",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_4",
        "name": "Thyroid function requirements",
        "identifier": "I7",
        "category": {
          "code": "Inclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Inclusion Criterion"
        },
        "criterionItemId": "eci_4",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_5",
        "name": "Contraceptive requirements",
        "identifier": "I9.1",
        "category": {
          "code": "Inclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Inclusion Criterion"
        },
        "criterionItemId": "eci_5",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_6",
        "name": "Transferred-entry subject alignment",
        "identifier": "I15",
        "category": {
          "code": "Inclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Inclusion Criterion"
        },
        "criterionItemId": "eci_6",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_7",
        "name": "Severe renal impairment exclusion",
        "identifier": "E31",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_7",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_8",
        "name": "Transferred-entry exclusion alignment",
        "identifier": "E32",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_8",
        "instanceType": "EligibilityCriterion"
      }
    ],
    "eligibilityCriterionItems": [
      {
        "id": "eci_1",
        "name": "Treatment-resistant depression definition",
        "text": "Treatment-resistant depression is defined as a lack of clinically meaningful improvement after treatment with at least 2 different antidepressant agents prescribed in adequate doses for adequate duration. The upper limit of ≤5 antidepressants is only applicable to the past 2 years of a current episode of depression in cases where the current episode is >2 years.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_2",
        "name": "Nonresponse improvement threshold",
        "text": "Nonresponse defined as ≤25% improvement per Massachusetts General Hospital - Antidepressant Treatment Response Questionnaire (MGH-ATRQ), which specifies at least 6 weeks of treatment at a minimum therapeutic dose.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_3",
        "name": "Site Independent Qualification Assessment",
        "text": "Site Independent Qualification Assessment confirms the subject's current major depressive episode, antidepressant treatment response in the current depressive episode, and severity of depression (required at Week 1 to be MADRS total score ≥28).",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_4",
        "name": "Thyroid function requirements",
        "text": "If the thyroid-stimulating hormone (TSH) value is outside the normal reference range, then the free thyroxine (FT4) level will be assessed. If the FT4 level is normal, then the subject can be enrolled. If the FT4 level is outside the normal reference range, then the subject is not eligible.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_5",
        "name": "Contraceptive requirements",
        "text": "Contraceptive use by men or women should be consistent with local regulations regarding the use of contraceptive methods for subjects participating in clinical studies. Includes strengthened definitions of women who are not of childbearing potential and requirements for highly effective methods of contraception.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_6",
        "name": "Transferred-entry subject alignment",
        "text": "Transferred-entry subjects must meet the same criteria at the point of entry to this study as the direct-entry subjects at the same time point (ie, beginning of optimization phase).",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_7",
        "name": "Severe renal impairment exclusion",
        "text": "Exclude subjects with severe renal impairment (creatinine clearance <30 mL/min).",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_8",
        "name": "Transferred-entry exclusion alignment",
        "text": "Transferred-entry subjects must meet none of the exclusion criteria applicable to direct-entry subjects at the beginning of the optimization phase.",
        "instanceType": "EligibilityCriterionItem"
      }
    ],
    "population": {
      "id": "pop_1",
      "name": "Treatment-Resistant Depression Population",
      "includesHealthySubjects": false,
      "plannedEnrollmentNumber": null,
      "plannedMinimumAge": null,
      "plannedMaximumAge": null,
      "plannedSex": [
        {
          "code": "Male",
          "codeSystem": "http://www.cdisc.org/USDM/sex",
          "decode": "Male"
        },
        {
          "code": "Female",
          "codeSystem": "http://www.cdisc.org/USDM/sex",
          "decode": "Female"
        }
      ],
      "criterionIds": [
        "ec_1",
        "ec_2",
        "ec_3",
        "ec_4",
        "ec_5",
        "ec_6",
        "ec_7",
        "ec_8"
      ],
      "instanceType": "StudyDesignPopulation"
    }
  }
}